Subjects n 93
Age , yr 58.8 ± 17.2
Gender (M/F) 29/64
BMI(Kg/m2) 28.2 ± 5.7
Symptoms (n= 93)  
Peripheral oedema 25.8(24)
Syncope 14 (13)
Chest pain 12.9 (12)
WHO FC ()  
I-II 38.7
III-IV 61.3
Group of PH ()  
I 50.5
II 20.4
III 9.7
IV 14
V 5.4
Pulmonary function  
FVC () 90.3 ± 21.8
FEV1 () 82.2 ± 24.2
TLC () 92.4 ± 18.3
DLCO () 63.4 ± 20.5
DLCO/VA 76.72 ± 20.6
PO2 69.3 ± 13.5
PCO2 39.2 ± 9.3
6MWD 387.8 ± 124.8
proBNP 2404.5 ± 4103.3
Haemodynamics  
sPAP, mmHg 64.2 ± 21.3
dPAP, mmHg 27.8 ±9.7
mPAP, mmHg 41.86 ±13.3
PCWP, mmHg 17.3 ± 7.2
TPG, mmHg 23.2 ±11.9
SvO2, 65.85 ±9.2
CO, L.min -1 4.8 ± 2.2
CI, L. Min-1 2.7 ± 1.3
PVR, din.seg.cm-5 432.4 ± 297.6
Note: *Values are shown as the mean ± SD. Abbreviations: BMI (body mass index), WHO (World Health Organization), FC (functional class), FVC (forced volume capacity), FEV1 (forced expiratory volume in 1 second), TLC (total lung capacity), DLCO (diffusing capacity of carbon monoxide), DLCO/VA (DLCO corrected for alveolar volume), 6MWD (6-min walk distance), proBNP (brain natriuretic peptide), sPAP (systolic pulmonary artery pressure), dPAP (diastolic pulmonary artery pressure), mPAP (mean pulmonary artery pressure), mPAP (mean pulmonary artery pressure), PCWP (pulmonary capillary wedge pressure), TGP (transpulmonary gradient), SvO2 (mixed venous oxygen saturation), CO (cardiac output), CI (cardiac index), PVR (pulmonary vascular resistance).
Table 1: Demographics and clinical characteristics at the time of diagnosis*